Overview

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect data on patients with severe uveitis that have required re-implantation of the sustained-release fluocinolone drug delivery device due to depletion of study drug in their previous implanted device.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborator:
Bausch & Lomb Incorporated
Treatments:
Fluocinolone Acetonide